β-Carotene stability and uptake by prostate cancer cells are dependent on delivery vehicle

Nutrition and Cancer

Volumn 36, Issue 2, 2000, Pages 185-190

  Williams, Alexa W ^a   Boileau, Thomas W M ^a   Clinton, Steven K ^b   Erdman Jr , John W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; BOVINE SERUM ALBUMIN; DISPERSANT; DRUG VEHICLE; LIPOSOME; SOLVENT; TETRAHYDROFURAN; WATER;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DISPERSION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG UPTAKE; HUMAN; HUMAN CELL; MISCIBILITY; PROSTATE ADENOCARCINOMA;

BOVINAE;

EID: 0033946838     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC3602_7     Document Type: Article

References (19)

1. Clinton, SK: Lycopene: chemistry, biology, and implications for health and disease. Nutr Rev 56, 35-51, 1998.
2. Stahl, W, and Sies, H: Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys 336, 1-9, 1996.
3. Clinton, SK, Emenhiser, C, Schwartz, SJ, Bostwick, DG, Williams, AW, et al.: cis-trans-Lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5, 823-833, 1996.
4. Giovannucci, E, Ascherio, A, Rimm, EB, Stampfer, MJ, Colditz, GA, et al.: Intake of carotenoids and retinol in relation to prostate cancer risk. JNCI 87, 1767-1776, 1995.
5. Cook, NR, Stampfer, MJ, Ma, J, Manson, JE, Sacks, FM, et al.: β-Carotene supplementation for patients with low baseline levels and decreased risk of total and prostate carcinoma. Cancer 86, 1783-1792, 1999.
6. Bertram, JS, Pung, A, Churley, M, Kappock, TJ, Wilkins, LR, et al.: Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis 12, 671-678, 1991.
7. Zhang, L-X, Cooney, RV, and Bertram, JS: Carotenoids enhance gap-junctional communication and inhibit lipid peroxidation in C3H/10T1/ 2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 12, 2109-2114, 1991.
8. Wamer, WG, Wei, RR, Matusik, JE, Kornhauser, A, and Dunkel, VC: β-Carotene uptake, metabolism, and distribution in BALB/c 3T3 cells. Nutr Cancer 19, 31-41, 1993.
9. Verdon, CP, and Blumberg, JB: An assay for the α-tocopherol-binding protein-mediated transfer of vitamin E between membranes. Anal Biochem 169, 109-120, 1988.
10. Grolier, P, Azais-Braesco, V, Zelmire, L, and Fessi, H: Incorporation of carotenoids in aqueous systems: uptake by cultured rat hepatocytes. Biochim Biophys Acta 1111, 135-138, 1992.
11. Martin, KR, Failla, ML, and Smith, JC, Jr: β-Carotene and lutein protect HepG2 human liver cells against oxidant-induced damage. J Nutr 126, 2098-2106, 1996.
12. Parker, RS: Absorption, metabolism, and transport of carotenoids. FASEB J 10, 542-551, 1996.
13. Williams, AW, Boileau, TWM, Zhou, JR, Clinton, SK, and Erdman, JW, Jr: β-Carotene modulates human prostate cancer cell growth and may undergo intracellular metabolism to retinol. J Nutr 30, 728-732, 2000.
14. Scita, G, Aponte, GW, and Wolf, G: Uptake and cleavage of β-carotene by cultures of rat small intestinal cells and human lung fibroblasts. J Nutr Biochem 3, 118-123, 1992.
15. Scita, G: The stability of β-carotene under different laboratory conditions. J Nutr Biochem 3, 124-128, 1992.
16. Gross, MD, Bishop, TD, Belcher, JD, and Jacobs, DR: Solubilization of β-carotene in culture media. Nutr Cancer 27, 174-176, 1997.
17. Oarada, M, Stahl, W, and Sies, H: Cellular levels of all-trans β-carotene under influence of 9-cis-β-carotene in FU-5 rat hepatoma cells. Biol Chem 374, 1075-1081, 1993.
18. Bertram, JS: Carotenoids and gene regulation. Nutr Rev 57, 182-191, 1999.
19. Esterbauer, H, Dieber-Rotheneder, M, Waeg, G, Puhl, H, and Tatzber, F: Endogenous antioxidants and lipoprotein oxidation. Biochem Soc Trans 18, 1059-1061, 1990.